Literature DB >> 35125727

Endothelial Activation Markers in Polytransfused Children with Beta Thalassemia: Study from a Tertiary Care Centre in India.

Tushar Subhash Pallewar1, Kusha Sharma1, Sunita Sharma2, Jagdish Chandra3, Anita Nangia2.   

Abstract

Beta thalassemia major is associated with a subclinical hypercoagulable state. Endothelial activation markers like soluble Intercellular adhesion molecule (sICAM-1) and E-selectin have been implicated in the pathogenesis of endothelial dysfunction and hemostatic alterations. In this study we aimed to study serum levels of sICAM-1 and E-selectin in polytransfused children with β thalassemia major and their association with serum ferritin and D-dimer levels. Sixty-two polytransfused β-thalassemia major children aged between 5 and 17 years and 26 age and gender matched healthy controls were enrolled in the study. Complete blood count with peripheral smear, liver function tests, serum ferritin, coagulation tests [PT, APTT, D-dimer] and endothelial activation marker tests [ICAM-1 and E-selectin] were performed. PT, APTT and D-dimer levels were significantly higher in beta-thalassemia major patients than in control group (p = 0.003, p < 0.001, p < 0.001 respectively). Mean ICAM-1 and E-selectin levels were 731.34 ± 343.97 ng/ml and 111.75 ± 40.13 ng/ml respectively which were significantly higher than control group (p < 0.001, p < 0.001 respectively). No significant correlation of ICAM-1 and E-selectin was observed with serum ferritin, PT, APTT and D-dimer levels. The findings of the present study suggest that there is ongoing subclinical activation of coagulation cascade and fibrinolytic system in these patients. Endothelial activation markers may be used as early indicators of endothelial dysfunction to assess the thrombotic complications in beta thalassemia. © Indian Society of Hematology and Blood Transfusion 2021.

Entities:  

Keywords:  Beta thalassemia; D-dimer; E-selectin; ICAM-1

Year:  2021        PMID: 35125727      PMCID: PMC8804016          DOI: 10.1007/s12288-021-01471-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  22 in total

1.  Study of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with β-thalassemia.

Authors:  Mahmoud Alhosiny Fayed; Hesham El-Sayed Abdel-Hady; Mona Mohammed Hafez; Osama Saad Salama; Youssef Abdelhalim Al-Tonbary
Journal:  Hematol Oncol Stem Cell Ther       Date:  2017-06-15

2.  Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.

Authors:  Constadina Aggeli; Charalambos Antoniades; Constadina Cosma; Christine Chrysohoou; Dimitris Tousoulis; Vasilios Ladis; Markisia Karageorga; Christos Pitsavos; Christodoulos Stefanadis
Journal:  Int J Cardiol       Date:  2005-10-20       Impact factor: 4.164

Review 3.  Thalassemia and the hypercoagulable state.

Authors:  Nongnuch Sirachainan
Journal:  Thromb Res       Date:  2013-09-27       Impact factor: 3.944

4.  Adhesion molecules and high-sensitivity C-reactive protein levels in patients with sickle cell beta-thalassaemia.

Authors:  Ino Kanavaki; Periklis Makrythanasis; Christina Lazaropoulou; Antonis Kattamis; Revekka Tzanetea; Vassiliki Kalotychou; Ioannis Rombos; Ioannis Papassotiriou
Journal:  Eur J Clin Invest       Date:  2011-05-25       Impact factor: 4.686

Review 5.  Endothelial injury in the initiation and progression of vascular disorders.

Authors:  Belay Tesfamariam; Albert F DeFelice
Journal:  Vascul Pharmacol       Date:  2006-12-06       Impact factor: 5.773

6.  Activated peripheral blood and endothelial cells in thalassemia patients.

Authors:  D S Kyriakou; M G Alexandrakis; E S Kyriakou; D Liapi; T V Kourelis; F Passam; A Papadakis
Journal:  Ann Hematol       Date:  2001-10       Impact factor: 3.673

7.  Coagulation defects in thalassemic patients.

Authors:  Mostafa M Abosdera; Alzahraa E Almasry; Ehab S Abdel-Moneim
Journal:  Pediatr Neonatol       Date:  2017-02-17       Impact factor: 2.083

8.  Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease.

Authors:  Vichai Atichartakarn; Suporn Chuncharunee; Napaporn Archararit; Umaporn Udomsubpayakul; Katcharin Aryurachai
Journal:  Acta Haematol       Date:  2014-02-11       Impact factor: 2.195

Review 9.  Coagulation in the pathophysiology of hemolytic anemias.

Authors:  Maria Domenica Cappellini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

10.  Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction.

Authors:  Wasinee Kheansaard; Kunwadee Phongpao; Kittiphong Paiboonsukwong; Kovit Pattanapanyasat; Pornthip Chaichompoo; Saovaros Svasti
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.